WO2005070027A3 - A novel nucleotide mixture for improved nucleic acid amplification performance - Google Patents

A novel nucleotide mixture for improved nucleic acid amplification performance Download PDF

Info

Publication number
WO2005070027A3
WO2005070027A3 PCT/US2005/002414 US2005002414W WO2005070027A3 WO 2005070027 A3 WO2005070027 A3 WO 2005070027A3 US 2005002414 W US2005002414 W US 2005002414W WO 2005070027 A3 WO2005070027 A3 WO 2005070027A3
Authority
WO
WIPO (PCT)
Prior art keywords
nucleic acid
acid amplification
novel nucleotide
nucleotide mixture
amplification performance
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2005/002414
Other languages
French (fr)
Other versions
WO2005070027A8 (en
WO2005070027A2 (en
Inventor
Brian Washburn
Douglas Lovern
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biomerieux Inc
Original Assignee
Biomerieux Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biomerieux Inc filed Critical Biomerieux Inc
Priority to EP05722543A priority Critical patent/EP1706512B1/en
Priority to DE602005011754T priority patent/DE602005011754D1/en
Priority to JP2006551422A priority patent/JP4866248B2/en
Publication of WO2005070027A2 publication Critical patent/WO2005070027A2/en
Publication of WO2005070027A3 publication Critical patent/WO2005070027A3/en
Anticipated expiration legal-status Critical
Publication of WO2005070027A8 publication Critical patent/WO2005070027A8/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/706—Specific hybridization probes for hepatitis
    • C12Q1/707—Specific hybridization probes for hepatitis non-A, non-B Hepatitis, excluding hepatitis D
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/6846—Common amplification features
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/6851—Quantitative amplification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/686—Polymerase chain reaction [PCR]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Analysing Materials By The Use Of Radiation (AREA)

Abstract

The present invention relates to modification of amplification buffer used in amplification reactions. The modifications result in a significant improvement in results of amplification In particular, the present invention provides methods and buffers for performing an amplification reaction utilizing a buffer comprising nucleotide triphosphates comprising treating the buffer to substitute a portion of the nucleotide triphosphates with nucleotide diphosphates.
PCT/US2005/002414 2004-01-23 2005-01-21 A novel nucleotide mixture for improved nucleic acid amplification performance Ceased WO2005070027A2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
EP05722543A EP1706512B1 (en) 2004-01-23 2005-01-21 A novel nucleotide mixture for improved nucleic acid amplification performance
DE602005011754T DE602005011754D1 (en) 2004-01-23 2005-01-21 NOVEL NUCLEOTIDE MIXTURE FOR AN IMPROVED NUCLEIC ACID AMPLIFICATION PROCESS
JP2006551422A JP4866248B2 (en) 2004-01-23 2005-01-21 Novel nucleotide mixtures for improved nucleic acid amplification performance

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US53881504P 2004-01-23 2004-01-23
US53881404P 2004-01-23 2004-01-23
US53881604P 2004-01-23 2004-01-23
USUS60/538,814 2004-01-23
USUS60/538,815 2004-01-23
USUS60/538,816 2004-01-23

Publications (3)

Publication Number Publication Date
WO2005070027A2 WO2005070027A2 (en) 2005-08-04
WO2005070027A3 true WO2005070027A3 (en) 2006-04-06
WO2005070027A8 WO2005070027A8 (en) 2006-07-27

Family

ID=34812082

Family Applications (2)

Application Number Title Priority Date Filing Date
PCT/US2005/002415 Ceased WO2005071117A2 (en) 2004-01-23 2005-01-21 Primer and probe design for efficient amplification and detection of hcv 3′ non-translating region
PCT/US2005/002414 Ceased WO2005070027A2 (en) 2004-01-23 2005-01-21 A novel nucleotide mixture for improved nucleic acid amplification performance

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PCT/US2005/002415 Ceased WO2005071117A2 (en) 2004-01-23 2005-01-21 Primer and probe design for efficient amplification and detection of hcv 3′ non-translating region

Country Status (6)

Country Link
US (3) US7364854B2 (en)
EP (3) EP1721015B1 (en)
JP (2) JP4866248B2 (en)
AT (3) ATE491810T1 (en)
DE (3) DE602005023586D1 (en)
WO (2) WO2005071117A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2147118A4 (en) * 2007-04-27 2010-09-01 Eragen Biosciences Inc Materials and methods for detection of hepatitis c virus
US8435741B2 (en) 2007-07-26 2013-05-07 Fujifilm Corporation Isothermal nucleic acid amplification method using surfactant
US20090162856A1 (en) * 2007-11-06 2009-06-25 Hayato Miyoshi Rna detection method
JP2012513757A (en) * 2008-12-31 2012-06-21 アボット・ラボラトリーズ Primer and probe for detection of hepatitis C virus

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19612779A1 (en) * 1996-03-29 1997-10-02 Boehringer Mannheim Gmbh Method for the specific amplification of long nucleic acids by PCR
WO1998044161A1 (en) * 1997-04-03 1998-10-08 Life Technologies, Inc. Compositions and methods for reverse transcriptase-polymerase chain reaction (rt-pcr)
EP1026261A2 (en) * 1999-02-03 2000-08-09 Ortho-Clinical Diagnostics, Inc. Enhancement of the specificity of nucleic acid amplification by carrier nucleic acid
US6271004B1 (en) * 1999-06-25 2001-08-07 Display Systems Biotech A/S Method for improved reverse transcription at high temperatures
US20020119534A1 (en) * 1996-11-14 2002-08-29 Hans-Georg Ihlenfeldt Stabilized aqueous nucleoside triphosphate solutions
WO2003054209A2 (en) * 2001-10-31 2003-07-03 Applera Corporation A method of reducing non-specific amplification in pcr

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09107970A (en) 1995-10-17 1997-04-28 Soyaku Gijutsu Kenkyusho:Kk Nucleic acid derived from hepatitis C virus and method for detecting virus using the nucleic acid
DE3164463D1 (en) * 1980-11-12 1984-08-02 Mitsubishi Chem Ind Glutamine derivatives usable for curing immune diseases, methods for their preparation and compositions comprising said derivatives
US5087565A (en) * 1984-07-02 1992-02-11 Du Pont Merck Pharmaceutical Company Synthetic process for preparation of 32 P-labeled nucleotides
EP0222889B1 (en) * 1985-05-15 1993-10-27 Amoco Corporation Cytidine analogs
US4876187A (en) 1985-12-05 1989-10-24 Meiogenics, Inc. Nucleic acid compositions with scissile linkage useful for detecting nucleic acid sequences
US5032511A (en) * 1987-03-31 1991-07-16 Mitsubishi Kasei Corporation DNA fragments coding for antigens specific to non-A non-B hepatitis, expression vectors containing said DNA fragments, transformants and process for producing said antigens
CA1340843C (en) 1987-07-31 1999-12-07 J. Lawrence Burg Selective amplification of target polynucleotide sequences
US5712088A (en) * 1987-11-18 1998-01-27 Chiron Corporation Methods for detecting Hepatitis C virus using polynucleotides specific for same
US5714596A (en) * 1987-11-18 1998-02-03 Chiron Corporation NANBV diagnostics: polynucleotides useful for screening for hepatitis C virus
US5698390A (en) * 1987-11-18 1997-12-16 Chiron Corporation Hepatitis C immunoassays
US5030557A (en) 1987-11-24 1991-07-09 Ml Technology Venture Means and method for enhancing nucleic acid hybridization
JP2650159B2 (en) 1988-02-24 1997-09-03 アクゾ・ノベル・エヌ・ベー Nucleic acid amplification method
CA2020958C (en) * 1989-07-11 2005-01-11 Daniel L. Kacian Nucleic acid sequence amplification methods
EP0419180B1 (en) 1989-09-18 1994-08-03 Canon Kabushiki Kaisha Ink jet recording head and ink jet apparatus having same
DE69131891T2 (en) * 1990-02-16 2000-06-15 F. Hoffmann-La Roche Ag, Basel IMPROVEMENTS IN THE SPECIFICITY AND PURPOSE OF THE POLYMERASE CHAIN REACTION
JP4137996B2 (en) 1992-05-06 2008-08-20 ジェン−プローブ・インコーポレイテッド Nucleic acid sequence amplification method, composition and kit
WO2002081494A1 (en) * 2001-03-26 2002-10-17 Sirna Therapeutics, Inc. Oligonucleotide mediated inhibition of hepatitis b virus and hepatitis c virus replication
US5648232A (en) * 1993-01-21 1997-07-15 The Secretary Of State For Defence In Her Britannic Majesty's Government Of The United Kingdom Of Great Britain And Northern Ireland Microbiological best method and reagents
AU699232B2 (en) * 1994-03-10 1998-11-26 Gen-Probe Incorporated Method for suppressing inhibition of enzyme-mediated reactions by ionic detergents
US6127116A (en) * 1995-08-29 2000-10-03 Washington University Functional DNA clone for hepatitis C virus (HCV) and uses thereof
US5874565A (en) * 1995-08-29 1999-02-23 Washington University Nucleic acids comprising a highly conserved novel 3 terminal sequence element of the hepatitis C virus
JP2000516468A (en) * 1996-08-14 2000-12-12 ライフ テクノロジーズ，インコーポレイテッド Stable compositions for nucleic acid amplification and sequencing
ZA989950B (en) * 1997-11-17 1999-05-04 Akzo Nobel Nv Transcription based amplification of double stranded DNA targets
KR20010043111A (en) * 1998-04-27 2001-05-25 랄프 이. 크리스토퍼슨 Enzymatic nucleic acid treatment of diseases or conditions related to hepatitis c virus infection
AU4515699A (en) 1998-06-26 2000-01-17 Akzo Nobel N.V. Tagging of rna amplicons generated by transcription-based amplification
US6638714B1 (en) 1999-02-03 2003-10-28 Ortho-Clinical Diagnostics, Inc. Oligonucleotide primers for efficient detection of hepatitis C virus (HCV) and methods of use thereof
DE60034884T2 (en) * 1999-06-04 2008-01-17 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services CLONED GENOME OF INFECTIOUS HEPATITIS C VIRUS GENOTYP 2A AND ITS USES
CA2392218A1 (en) * 1999-11-17 2001-05-25 Jiuping Ji Simultaneous detection of hbv, hcv and hiv in plasma samples using a multiplex capture assay
AU2001254670A1 (en) 2000-03-02 2001-09-12 Akzo Nobel N.V. Detection of hepatitis b virus rna
WO2003016572A1 (en) * 2001-08-17 2003-02-27 Eli Lilly And Company Oligonucleotide therapeutics for treating hepatitis c virus infections
US6750009B2 (en) 2002-01-29 2004-06-15 Apath, Llc Multiple viral replicon culture systems
WO2003100014A2 (en) 2002-05-24 2003-12-04 Smithkline Beecham Corporation Method for quantitating negative strand rna synthesis

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19612779A1 (en) * 1996-03-29 1997-10-02 Boehringer Mannheim Gmbh Method for the specific amplification of long nucleic acids by PCR
US20020119534A1 (en) * 1996-11-14 2002-08-29 Hans-Georg Ihlenfeldt Stabilized aqueous nucleoside triphosphate solutions
WO1998044161A1 (en) * 1997-04-03 1998-10-08 Life Technologies, Inc. Compositions and methods for reverse transcriptase-polymerase chain reaction (rt-pcr)
EP1026261A2 (en) * 1999-02-03 2000-08-09 Ortho-Clinical Diagnostics, Inc. Enhancement of the specificity of nucleic acid amplification by carrier nucleic acid
US6271004B1 (en) * 1999-06-25 2001-08-07 Display Systems Biotech A/S Method for improved reverse transcription at high temperatures
WO2003054209A2 (en) * 2001-10-31 2003-07-03 Applera Corporation A method of reducing non-specific amplification in pcr

Also Published As

Publication number Publication date
EP2042612A2 (en) 2009-04-01
JP2007518424A (en) 2007-07-12
US7364854B2 (en) 2008-04-29
WO2005070027A8 (en) 2006-07-27
US7670779B2 (en) 2010-03-02
WO2005071117A3 (en) 2006-04-20
WO2005071117A2 (en) 2005-08-04
US20080248480A1 (en) 2008-10-09
DE602005025424D1 (en) 2011-01-27
EP1721015A2 (en) 2006-11-15
EP2042612B1 (en) 2010-12-15
EP1706512A2 (en) 2006-10-04
US20060019266A1 (en) 2006-01-26
DE602005023586D1 (en) 2010-10-28
EP2042612A3 (en) 2009-06-17
EP1721015B1 (en) 2010-09-15
ATE417938T1 (en) 2009-01-15
US20060003343A1 (en) 2006-01-05
JP4866248B2 (en) 2012-02-01
ATE491810T1 (en) 2011-01-15
ATE481507T1 (en) 2010-10-15
WO2005070027A2 (en) 2005-08-04
DE602005011754D1 (en) 2009-01-29
JP2007518425A (en) 2007-07-12
EP1706512B1 (en) 2008-12-17

Similar Documents

Publication Publication Date Title
WO2002101022A3 (en) Method for rapid amplification of dna
WO2008051530A3 (en) Polymerase enzymes and reagents for enhanced nucleic acid sequencing
WO2006005074A3 (en) Novel hot start nucleic acid amplification
WO2007005645A3 (en) Materials and methods for the generation of fully 2'-modified nucleic acid transcripts
WO2003064691A3 (en) Methods and means for amplifying nucleic acid
WO2009102896A3 (en) Isothermal nucleic acid amplification methods and compositions
WO2006002038A3 (en) Immunostimulatory oligonucleotide multimers
MY143596A (en) In vitro recombination method
WO2005044836A3 (en) Macromolecular nucleotide compounds and methods for using the same
BR0101493B1 (en) Method for reverse transcription and amplification of an RNA using mutant polymerases.
WO2009086608A3 (en) Method and kit to perform a pcr amplification and micro- array detection in the same medium and/or same chamber
WO2004021986A3 (en) Improved compositions and methods for cdna synthesis
WO2007062160A3 (en) Methods and compositions for sequencing a nucleic acid
WO2004074503A3 (en) Nucleic acid sequencing methods, kits and reagents
WO2004092418A3 (en) Global amplification using a randomly primed composite primer
WO2005059097A3 (en) Methods for high fidelity production of long nucleic acid molecules
NO20072507L (en) Reagents and Methods to Improve Reproducibility and Reduce Wrong Priming in PCR Amplification
WO2008076842A3 (en) Sequencing methods
WO2006003439A3 (en) Method for stabilising reagents which are useful for nucleic acid amplification
WO2004104229A3 (en) Internal control nucleic acid molecule for nucleic acid amplification systems
WO2009054510A1 (en) Isothermal amplification method and dna polymerase used in the same
WO2007057167A3 (en) A method for enhancing enzymatic dna polymerase reactions
WO2003004703A1 (en) Process for producing template dna and process for producing protein in cell-free protein synthesis system with the use of the same
WO2005070027A3 (en) A novel nucleotide mixture for improved nucleic acid amplification performance
WO2005113760A3 (en) Thermostable y-family polymerases and chimeras

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

WWE Wipo information: entry into national phase

Ref document number: 2005722543

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2006551422

Country of ref document: JP

NENP Non-entry into the national phase

Ref country code: DE

WWW Wipo information: withdrawn in national office

Country of ref document: DE

WWP Wipo information: published in national office

Ref document number: 2005722543

Country of ref document: EP